Measuring The Risks And Causes Of Premature Death

Measuring the Risks and Causes of Premature Death is the summary of two workshops conducted by The Committee on Population of the National Research Council at the National Academies to address the data sources, science and future research needs to understand the causes of premature mortality in the United States. The workshops reviewed previous work in the field in light of new data generated as part of the work of the NRC Panel on Understanding Divergent Trends in Longevity in High-Income Countries (NRC, 2011) and the NRC/IOM Panel on Understanding Cross-National Differences Among High-Income Countries (NRC/IOM, 2013). The workshop presentations considered the state of the science of measuring the determinants of the causes of premature death, assessed the availability and quality of data sources, and charted future courses of action to improve the understanding of the causes of premature death. Presenters shared their approaches to and results of measuring premature mortality and specific risk factors, with a particular focus on those factors most amenable to improvement through public health policy. This report summarizes the presentations and discussion of both workshops.

"Measuring the Risks and Causes of Premature Death" is the summary of two workshops conducted by The Committee on Population of the National Research Council at the National Academies to address the data sources, science and future research needs to understand the causes of premature mortality in the United States. The workshops reviewed previous work in the field in light of new data generated as part of the work of the NRC Panel on Understanding Divergent Trends in Longevity in High-Income Countries (NRC, 2011) and the NRC/IOM Panel on Understanding Cross-National Differences Among High-Income Countries (NRC/IOM, 2013). The workshop presentations considered the state of the science of measuring the determinants of the causes of premature death, assessed the availability and quality of data sources, and charted future courses of action to improve the understanding of the causes of premature death. Presenters shared their approaches to and results of measuring premature mortality and specific risk factors, with a particular focus on those factors most amenable to improvement through public health policy. This report summarizes the presentations and discussion of both workshops.

The Global Burden of Disease (GBD) provides systematic epidemiological estimates for an unprecedented 150 major health conditions. The GBD provides indispensable global and regional data for health planning, research, and education.

Provides a comprehensive assessment of the scientific evidence on prevalence and the resulting health effects of a range of exposures that are know to be hazardous to human health, including childhood and maternal undernutrition, nutritional and physiological risk factors for adult health, addictive substances, sexual and reproductive health risks, and risks in the physical environments of households and communities, as well as among workers. This book is the culmination of over four years of scientific equiry and data collection, know as the comparative risk assessment (CRA) project.

The global burden of disease: 2004 update is a comprehensive assessment of the health of the world's population. It provides detailed global and regional estimates of premature mortality, disability and loss of health for 135 causes by age and sex, drawing on extensive WHO databases and on information provided by Member States.--Publisher description.

Social isolation and loneliness are serious yet underappreciated public health risks that affect a significant portion of the older adult population. Approximately one-quarter of community-dwelling Americans aged 65 and older are considered to be socially isolated, and a significant proportion of adults in the United States report feeling lonely. People who are 50 years of age or older are more likely to experience many of the risk factors that can cause or exacerbate social isolation or loneliness, such as living alone, the loss of family or friends, chronic illness, and sensory impairments. Over a life course, social isolation and loneliness may be episodic or chronic, depending upon an individual's circumstances and perceptions. A substantial body of evidence demonstrates that social isolation presents a major risk for premature mortality, comparable to other risk factors such as high blood pressure, smoking, or obesity. As older adults are particularly high-volume and high-frequency users of the health care system, there is an opportunity for health care professionals to identify, prevent, and mitigate the adverse health impacts of social isolation and loneliness in older adults. Social Isolation and Loneliness in Older Adults summarizes the evidence base and explores how social isolation and loneliness affect health and quality of life in adults aged 50 and older, particularly among low income, underserved, and vulnerable populations. This report makes recommendations specifically for clinical settings of health care to identify those who suffer the resultant negative health impacts of social isolation and loneliness and target interventions to improve their social conditions. Social Isolation and Loneliness in Older Adults considers clinical tools and methodologies, better education and training for the health care workforce, and dissemination and implementation that will be important for translating research into practice, especially as the evidence base for effective interventions continues to flourish.

Strategic health planning, the cornerstone of initiatives designed to achieve health improvement goals around the world, requires an understanding of the comparative burden of diseases and injuries, their corresponding risk factors and the likely effects of invervention options. The Global Burden of Disease framework, originally published in 1990, has been widely adopted as the preferred method for health accounting and has become the standard to guide the setting of health research priorities. This publication sets out an updated assessment of the situation, with an analysis of trends observed since 1990 and a chapter on the sensitivity of GBD estimates to various sources of uncertainty in methods and data.

The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illnesses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, "peer" countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.